Detalhe da pesquisa
1.
NMDA receptor GluN2D subunit participates to levodopa-induced dyskinesia pathophysiology.
Neurobiol Dis
; 121: 338-349, 2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30261285
2.
Rabphilin 3A: A novel target for the treatment of levodopa-induced dyskinesias.
Neurobiol Dis
; 108: 54-64, 2017 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-28823933
3.
Increased [³H]D-aspartate release and changes in glutamate receptor expression in the hippocampus of the mnd mouse.
J Neurosci Res
; 90(6): 1148-58, 2012 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-22302580
4.
Modulatory effect of acetyl-L-carnitine on amyloid precursor protein metabolism in hippocampal neurons.
Eur J Pharmacol
; 597(1-3): 51-6, 2008 Nov 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-18801359
5.
Expression of AMPA and NMDA receptor subunits in the cervical spinal cord of wobbler mice.
BMC Neurosci
; 7: 71, 2006 Oct 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-17067377
6.
NMDA receptor GluN2A/GluN2B subunit ratio as synaptic trait of levodopa-induced dyskinesias: from experimental models to patients.
Front Cell Neurosci
; 9: 245, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-26217176
7.
Amyloid precursor protein metabolism is regulated toward alpha-secretase pathway by Ginkgo biloba extracts.
Neurobiol Dis
; 16(2): 454-60, 2004 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-15193301